Loading...
Neuronetics, Inc.
STIM•NASDAQ
Healthcare
Medical - Diagnostics & Research
$4.49
$0.04(0.90%)
Neuronetics, Inc. (STIM) Financial Performance & Income Statement Overview
Review Neuronetics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.96%
↑ 4.96%
Operating Income Growth
-13.12%
↓ 13.12%
Net Income Growth
-44.78%
↓ 44.78%
Operating Cash Flow Growth
3.25%
↑ 3.25%
Operating Margin
-43.29%
↓ 43.29%
Gross Margin
63.51%
↑ 63.51%
Net Profit Margin
-53.67%
↓ 53.67%
ROE
-208.89%
↓ 208.89%
ROIC
-33.05%
↓ 33.05%
Neuronetics, Inc. (STIM) Income Statement & Financial Overview
Review Neuronetics, Inc.'s (STIM) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $22.49M | $18.53M | $16.45M | $17.42M |
| Cost of Revenue | $7.60M | $4.53M | $4.27M | $4.89M |
| Gross Profit | $14.89M | $14.001M | $12.18M | $12.53M |
| Gross Profit Ratio | $0.66 | $0.76 | $0.74 | $0.72 |
| R&D Expenses | $5.77M | $2.42M | $2.23M | $2.35M |
| SG&A Expenses | $20.59M | $19.31M | $18.45M | $17.04M |
| Operating Expenses | $26.36M | $21.73M | $20.69M | $19.39M |
| Total Costs & Expenses | $33.44M | $26.26M | $24.96M | $24.28M |
| Interest Income | -$14000.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.76M | $1.73M | $1.98M | $1.83M |
| Depreciation & Amortization | $442000.00 | $512000.00 | $555000.00 | $560000.00 |
| EBITDA | -$11.28M | -$11.10M | -$7.30M | -$5.49M |
| EBITDA Ratio | -$0.50 | -$0.60 | -$0.44 | -$0.32 |
| Operating Income | -$11.47M | -$7.73M | -$8.51M | -$6.86M |
| Operating Income Ratio | -$0.51 | -$0.42 | -$0.52 | -$0.39 |
| Other Income/Expenses (Net) | -$686000.00 | -$5.61M | -$1.32M | -$1.01M |
| Income Before Tax | -$12.16M | -$13.34M | -$9.83M | -$7.87M |
| Income Before Tax Ratio | -$0.54 | -$0.72 | -$0.60 | -$0.45 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $516724.00 |
| Net Income | -$12.16M | -$13.34M | -$9.83M | -$7.87M |
| Net Income Ratio | -$0.54 | -$0.72 | -$0.60 | -$0.45 |
| EPS | -$0.33 | -$0.44 | -$0.33 | -$0.27 |
| Diluted EPS | -$0.33 | -$0.44 | -$0.33 | -$0.27 |
| Weighted Avg Shares Outstanding | $36.67M | $30.27M | $30.05M | $29.47M |
| Weighted Avg Shares Outstanding (Diluted) | $36.67M | $30.27M | $30.05M | $29.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan